What is the pathophysiology of posterior subcapsular cataract?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Posterior Subcapsular Cataract

Posterior subcapsular cataracts (PSCs) develop through a two-stage process involving oxidative stress, lens epithelial cell migration, and inflammation that leads to characteristic opacification at the posterior pole of the lens. 1

Types and Morphology

Two distinct types of posterior subcapsular cataracts have been identified:

  1. Vacuolar-lacy type:

    • More superficial (closer to posterior capsule)
    • Characterized by cellular proliferation
    • Seen in senile, diabetic, retinitis pigmentosa, steroid-induced, and secondary cataracts
    • Contains aberrantly migrated lens epithelial cells
    • These cells secrete basement membrane, filaments, and release cytolytic lysozymes
  2. Solid plaque type:

    • Located slightly deeper in the cortical region
    • Acellular in nature
    • Observed in congenital polar cataracts, myotonic dystrophy, and Turner syndrome
    • Shows breakdown of lens fibers into disorganized globules and membranous whorls 2

Two-Stage Pathophysiological Process

Stage I (Early Development)

  • Triggered by risk factors promoting oxidative stress and ion-pump disruption
  • Damages lens fibers
  • Causes aberrant lens epithelial cells (LECs) to proliferate
  • LECs migrate ectopically as Wedl cells to the posterior pole region
  • May involve epithelial-to-mesenchymal transition (EMT) 1

Stage II (Progression)

  • Follows a latent period
  • Characterized by chronic inflammation
  • Premature aging-related mechanisms advance
  • Results in mature vacuolar or plaque PSC formation 1

Key Molecular and Cellular Mechanisms

  • Lens epithelial cell dysfunction: LECs are normally hypoxic and highly sensitive to oxidative stress 1
  • Epithelial-mesenchymal transition: LECs transform into myofibroblast-like cells 3
  • Aberrant migration: LECs migrate posteriorly instead of equatorially 2
  • Protein expression changes:
    • Decreased expression of ephrin type-A receptor 2 (EphA2)
    • Increased expression of α-smooth muscle actin (α-SMA)
    • Altered expression of αB-crystallin (CRYAB) and heat shock protein beta-1 (HSPB1) 4
  • Extracellular matrix deposition: Collagen accumulation and basement membrane secretion 3, 2
  • Cellular proliferation: Unregulated growth of lens epithelial cells 3
  • Lens fiber generation: Abnormal lens fiber formation 3

Risk Factors Contributing to PSC Development

Several factors can initiate the pathophysiological cascade:

  • Aging: Natural degenerative processes
  • Diabetes: Metabolic disruption and oxidative stress
  • Steroid use: Alters lens epithelial cell function and migration
  • Ionizing radiation: Directly damages LECs and increases oxidative stress
  • UV-B exposure: Associated with increased risk of PSC formation 5
  • Ocular conditions: Retinitis pigmentosa, uveitis, vitrectomy
  • Systemic conditions: Hypoparathyroidism, myopia, atopy
  • Solar radiation: Contributes to oxidative damage 1, 5

Clinical Implications

  • The vacuolar type is more readily removed during extracapsular cataract extraction
  • Retention of nucleated lens epithelial cells in vacuolar opacities can lead to secondary cataracts (Hirchberg-Elschnig pearls)
  • Secondary cataracts may require additional procedures to clear the visual axis 2
  • Posterior capsular opacification (PCO) remains a common complication after cataract surgery, requiring Nd:YAG laser capsulotomy 3

Prevention Considerations

  • Potential for reducing PSC incidence by targeting Stage I mechanisms
  • Ocular antioxidants may help counteract oxidative stress
  • Improvements in surgical techniques, intraocular lens materials, and designs have reduced PCO rates 1, 3

References

Research

Human posterior subcapsular cataracts.

Transactions of the ophthalmological societies of the United Kingdom, 1982

Research

Posterior capsular opacification: a problem reduced but not yet eradicated.

Archives of ophthalmology (Chicago, Ill. : 1960), 2009

Research

A Human Three-Dimensional In Vitro Model of Lens Epithelial Cells as a Model to Study Mechanisms of Drug-Induced Posterior Subcapsular Cataracts.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2020

Research

Ultraviolet light exposure and risk of posterior subcapsular cataracts.

Archives of ophthalmology (Chicago, Ill. : 1960), 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.